TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502): Reassessing Valuation After Positive 52-Week Rusfertide Phase 3 Data

Takeda Pharmaceutical (TSE:4502) is back in focus after presenting new 52 week Phase 3 VERIFY data for rusfertide in polycythemia vera at the American Society of Hematology meeting, underscoring durable efficacy and a consistent safety profile. See our latest analysis for Takeda Pharmaceutical. The latest rusfertide update lands against a backdrop of steady gains, with Takeda Pharmaceutical’s share price up over the year and a solid multi year total shareholder return suggesting gradually...
TSE:9531
TSE:9531Gas Utilities

Tokyo Gas (TSE:9531) Valuation Check as It Commits Major Capital to US Gas Infrastructure Expansion

Tokyo GasLtd (TSE:9531) just signaled a bigger push into the US, earmarking hundreds of billions of yen for downstream assets such as liquefaction plants and export terminals to tighten its global gas supply chain. See our latest analysis for Tokyo GasLtd. That planned US expansion comes on the back of a powerful rally, with Tokyo GasLtd’s share price up around 42 percent year to date and a hefty 1 year total shareholder return near 44 percent, signaling still strong momentum despite today’s...
TSE:7906
TSE:7906Leisure

YONEX (TSE:7906): Revisiting Valuation After a Sharp Pullback in a Strong Multi‑Year Rally

YONEX (TSE:7906) has been on a mixed run lately, with the stock easing over the past month even after strong gains this year. That pullback is prompting investors to revisit the valuation. See our latest analysis for YONEX. Despite the recent 1 month share price return of negative 12.6% as investors cool on cyclical consumer names, YONEX still has a robust year to date share price return of over 50 percent and a five year total shareholder return above 450 percent. This suggests long term...
TSE:278A
TSE:278ACommercial Services

Terra Drone (TSE:278A) Loss Widens Year on Year, Testing Growth-Led Bullish Narratives

Terra Drone (TSE:278A) just posted its Q3 2026 numbers with revenue of 1,229 million JPY and basic EPS of -9.36 JPY, setting the stage for another loss making quarter despite steady top line scale. The company has seen revenue move from 1,205 million JPY in Q3 2025 to 1,229 million JPY in Q3 2026, while basic EPS has swung from 3.67 JPY to -9.36 JPY. This underscores pressure on margins even as the business continues to grow its sales base. See our full analysis for Terra Drone. With the...
TSE:7110
TSE:7110Multiline Retail

Kurashicom (TSE:7110) Q1 EPS Jump Reinforces Bullish Profitability Narratives

Kurashicom (TSE:7110) Q1 2026 Results in Focus Kurashicom (TSE:7110) has opened fiscal 2026 with Q1 revenue of ¥2.4 billion and EPS of ¥29.7, alongside net income of ¥219 million that anchors the latest set of reported numbers. Over the past few quarters, the company has seen revenue move from ¥1.9 billion in Q1 2025 to ¥2.0 billion in Q4 2025 and now ¥2.4 billion in Q1 2026. Quarterly EPS has shifted from ¥10.6 in Q1 2025 to ¥19.9 in Q4 2025 and ¥29.7 in the latest quarter, giving investors...